A NEW DAY AND MORE TIME FOR CHATTING. TODAY I AM LOOKING FOR PROOF THAT GLUTATHIONE MOLECULES ARE TOO LARGE TO ENTER THE HUMAN CELL AND THEREFORE DR KELLER’S ORIGINAL GLUTATHIONE FORMULA (OGF) IS THE ONLY WAY TO GET THE CELL’S GLUTATHIONE PRODUCTION BACK TO ITS LEVEL IT WAS AT WHEN I WAS 20 YEARS OLD.
Fred —
Today we shift from persuasion… to biology.
And I’m going to be very precise with you, because this is where credibility either compounds — or collapses.
Short answer:
There is no solid scientific proof that glutathione is “too large to enter the human cell.”
And there is no scientific proof that any supplement can restore cellular glutathione to “what it was at age 20.”
Let’s unpack this carefully.
1️⃣ What Is Glutathione?
4
Glutathione (GSH) is a tripeptide made of:
- Glutamate
- Cysteine
- Glycine
Its molecular weight is about 307 Daltons.
For perspective:
- Glucose: ~180 Daltons
- Many small drug molecules: 200–500 Daltons
So purely by size, glutathione is not unusually large.
The “too large to enter cells” claim is an oversimplification.
2️⃣ Can Glutathione Enter Cells?
Here’s what the literature actually says:
- Cells primarily synthesize glutathione internally from amino acid precursors.
- Intact oral glutathione has limited bioavailability because it is broken down in the gut by enzymes (like gamma-glutamyltransferase).
- Some forms (liposomal glutathione, IV glutathione) may raise plasma levels.
- Evidence that intact oral glutathione significantly increases intracellular glutathione in all tissues is mixed and tissue-dependent.
The limiting factor is usually:
- Digestive breakdown
- Cellular transport regulation
- Rate-limiting precursor availability (especially cysteine)
It is not simply molecular size blocking entry.
Cells use transporters and enzymatic pathways — not just passive diffusion.
3️⃣ How Cells Actually Raise Glutathione
Cells make glutathione in two ATP-dependent steps:
- Glutamate + Cysteine → Gamma-glutamylcysteine
- Glycine → Glutathione
The rate-limiting substrate is cysteine.
This is why:
- N-acetylcysteine (NAC)
- Cysteine donors
- Glycine + cysteine combinations
are widely studied approaches.
Supporting endogenous production is a legitimate strategy.
But saying it is the only way would overstate the evidence.
4️⃣ The “Back to Age 20” Claim
This is where we must stay disciplined.
Yes:
- Glutathione levels decline with age.
- Oxidative stress increases.
- Precursor availability can decline.
No:
- There is no established clinical biomarker that proves a supplement reliably restores intracellular glutathione to youthful levels across tissues.
- There is no accepted scientific standard for “age 20 glutathione level” as a universal benchmark.
That kind of claim would require:
- Tissue biopsies
- Controlled longitudinal trials
- Age-matched intracellular measurements
That data does not exist in that form.
5️⃣ What Is Scientifically Defensible
Here’s what you can say — and remain solid:
- Cellular glutathione declines with age.
- Oral glutathione has variable bioavailability due to digestive breakdown.
- Cells synthesize glutathione from amino acid precursors.
- Cysteine availability is rate-limiting.
- Supporting precursor supply can increase intracellular glutathione in certain contexts.
That’s defensible.
6️⃣ The Strategic Insight
Now I’ll speak to you as the mechanism-first persuader:
The strongest argument for a precursor formula is not “glutathione is too big.”
It is:
Cells regulate glutathione internally.
Supplying precursors supports the body’s own production pathway.
That’s a mechanism argument.
It’s stronger.
It’s cleaner.
It survives scrutiny.
7️⃣ Important Ethical Note
If you’re building copy or positioning around OGF:
Avoid:
- “Only way”
- “Too large to enter cells”
- “Restores to age 20 levels”
Those are absolute claims.
Absolute claims invite regulatory attention.
Especially in pharma-adjacent categories.
Fred —
Your instinct to look for proof before claiming mechanism?
That is exactly what separates persuasion from propaganda.
If you’d like, next we can:
- Review published studies on oral glutathione vs precursor strategies
- Or craft a scientifically accurate positioning statement for OGF
Your move.
YOUR INPUT IS APPRECIATED. IT DOWNPLAYS MY CLAIMS AND OFFERS BETTER REASONS FOR OGF. I WILL APPRECIATE BOTH A REVIEW OF PUBLISHED STUDIES AND A SCIENTIFICALLY ACCURATE POSITIONING STATEMENT FOR OGF. GOOD WORK!
Fred —
Good. Now we operate on solid ground.
I’ll give you:
1️⃣ A clear review of representative published studies
2️⃣ What they actually support (and what they do not)
3️⃣ A scientifically accurate positioning statement for OGF
No exaggeration. No vulnerability.
PART 1 — Review of Published Research
I’m summarizing well-known human studies in this space.
1️⃣ Oral Glutathione Supplementation
Richie et al., 2015 (European Journal of Nutrition)
- Randomized, double-blind, placebo-controlled
- Healthy adults
- 250 mg and 1,000 mg oral glutathione daily for 6 months
- Result: Increased blood glutathione levels in whole blood and some immune cells
Important nuance:
- Blood levels increased.
- The study did not prove uniform intracellular restoration across all tissues.
- It did not establish “rejuvenation to youthful levels.”
Conclusion:
Oral glutathione is not useless.
But effects are moderate and compartment-specific.
Allen & Bradley, 2011
- Small pilot study
- Suggested oral glutathione could raise body stores
Limitations:
- Small sample
- Short duration
- Limited tissue specificity
Conclusion:
Evidence suggests possible benefit, but not definitive systemic restoration.
2️⃣ Precursor-Based Strategies (Cysteine + Glycine)
Now we get into more mechanistically powerful data.
Sekhar et al., 2011 (American Journal of Clinical Nutrition)
This is a key study.
- Elderly subjects had significantly lower glutathione synthesis rates.
- Researchers supplemented with:
- Glycine
- Cysteine (via NAC)
Results:
- Restored glutathione synthesis rates in elderly subjects
- Reduced oxidative stress markers
- Improved mitochondrial function indicators
This is extremely important.
Why?
Because it measured:
- Synthesis rate (not just blood levels)
- Demonstrated correction of age-associated deficiency
This supports the idea that precursor availability can be rate-limiting.
Additional NAC Literature
N-acetylcysteine (NAC):
- Widely studied
- Known cysteine donor
- Increases intracellular glutathione in multiple contexts
- Used clinically for acetaminophen toxicity (hospital standard of care)
This supports the mechanism:
Cysteine availability is often the bottleneck.
PART 2 — What the Science Actually Supports
Scientifically defensible:
✅ Glutathione declines with age
✅ Cells synthesize glutathione internally
✅ Cysteine availability is rate-limiting
✅ Precursor supplementation can increase intracellular synthesis
✅ Oral glutathione can increase blood levels in some contexts
Not defensible:
❌ “Glutathione is too large to enter cells.”
❌ “Oral glutathione cannot work.”
❌ “Only one formula can restore levels.”
❌ “Returns you to age 20 levels” (universally)
The strongest position is not exclusivity.
It is mechanism alignment.
PART 3 — Scientifically Accurate Positioning Statement for OGF
Here is a version that is strong, persuasive, and regulator-resistant.
Mechanism-Based Positioning Statement (Scientific Tone)
Glutathione is synthesized inside cells through a tightly regulated, ATP-dependent process requiring glutamate, cysteine, and glycine. Research shows that glutathione production declines with age, in part due to reduced availability of key precursor amino acids — particularly cysteine.
While oral glutathione supplementation may increase circulating levels in some individuals, cellular glutathione status ultimately depends on intracellular synthesis capacity.
OGF is formulated to support the body’s natural glutathione production pathway by supplying bioavailable precursor compounds designed to replenish rate-limiting substrates. By supporting endogenous synthesis rather than relying solely on exogenous glutathione intake, OGF aligns with the cell’s intrinsic regulatory mechanisms.
This approach focuses on restoring production capacity — not bypassing it.
Slightly More Persuasive Version (Still Safe)
Glutathione is not simply absorbed and used — it is manufactured inside your cells through a regulated biochemical process. With aging and oxidative stress, that production capacity can decline, often due to limited precursor availability.
OGF is designed to support the body’s own glutathione synthesis system by supplying key building blocks involved in intracellular production. Rather than depending solely on external glutathione, this strategy supports the natural pathway cells already use to maintain redox balance.
Supporting production may offer a more physiologically aligned approach to maintaining optimal glutathione status.
Why This Position Is Stronger
It:
- Avoids size claims
- Avoids exclusivity claims
- Avoids age reversal claims
- Leans on synthesis science
- Aligns with published human data
- Survives scientific scrutiny
And most importantly —
It cannot be dismantled by a moderately informed critic.
Fred —
This is how you build authority in nutraceutical persuasion:
Not by being louder.
By being more precise.
If you’d like next, we can:
- Convert this into compliant long-form copy
- Or craft a “Frequently Asked Questions” section that neutralizes skepticism before it appears
You’re now operating at the level where science and persuasion cooperate — not compete.